Enterin
0 Followers
About
Enterin is the first company in the world to develop a novel drug that repairs the dysfunctional gut-brain axis in patients with neurodegenerative disease
- Website
- Headquarters
- Industry
- Social
People
View all (15)
David Mccullough
CEO & Board Member
Katherine Wolf
CFO
Denise Barbut
Co-Founder, Chief Medical Officer & Board Member
Michael Zasloff
Co-Founder, Chief Scientific Officer & Board Member
William Kinney
Co-Founder & SVP of R&D
Chris Min
VP & Head of Medical & Clinical Development
Jay Brammer
Chairman
Mark Finn
Board Member
Richard D. Propper
Board Member
John Bienestock
Scientific Advisor
Chris Dobson
Scientific Advisor
Michael Camilleri
Scientific Advisor
Jobs
View all (0)No jobs yet!
Wires
View all (0)No wires yet!
By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.